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Introduction: Potential stem cell niches (SNs) were recently reported in intervertebral discs (IVDs) and knee joints
(KJs) in different mammals (located adjacent to the epiphyseal plate; EP). The aim here was to examine further
possible cellular migration and migration directions of cells originating from niches possibly involved in
regeneration of cartilaginous tissues in the IVD and in the KJ regions in adult mammals.
Methods: In total, 33 rabbits were used in studies A through C.
A. IVD cells were sorted; fluorescence-activated cell sorting (FACS) by size (forward scatter; ≤10 μm or >10 μm or
GDF5+ cells (anti-GDF5 antibody). Sorted cells, labeled with cell tracer (carboxyfluorescein-diacetate-
succinimidyl ester; CDFA-SE) were applied on IVD explants in vitro. Migrating cells/distance was evaluated by
fluorescence- and confocal-microscopy (FC).
B. DNA labeling was performed with BrdU (oral administration). Animals were killed (14 to 56 days), KJs collected,
and BrdU+ cells visualized with immunohistochemistry (IHC)/anti-BrdU antibody in SN and articular cartilage (AC).
C. Cell tracer: (Fe-nanoparticles: Endorem) were injected into SNs of IVDs (LI-LV) and KJs (tibia). Animals were
killed after 2 to 6 weeks. Fe-labeled cells were traced by ferric-iron staining (Prussian blue reaction; Mallory
method).
Results: A. GDF5+ cells and ≤10-μm cells displayed the best migration capability in IVD explants. GDF5+ cells were
detected at a tissue depth of 1,300 μm (16 days). B. BrdU+ cells were observed in early time points in niches of KJs,
and at later time points in AC, indicating a gradual migration of cells. C. Fe+ cells were detected in IVDs; in annulus
fibrosus (AF) in 11 of 12 animals and in nucleus pulposus (NP) in two of 12 animals. In AC (tibia), Fe+ cells were
detected in six of 12 animals. In the potential migration route (PMR), from niches toward the IVD, Fe+ cells (three of
12 animals) and in PMR toward AC (KJs) (six of 12 animals) were detected.
Conclusions: Results indicate similar cellular migration patterns in cartilage regions (IVD and KJs) with migration
from stem cell niche areas into the mature cartilaginous tissues of both the KJs and the IVD. These findings of a
cellular migration pattern in mature cartilage are of interest from tissue-repair and engineering perspectives.* Correspondence: helena.barreto.henriksson@gu.se
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Musculoskeletal diseases represent a major part of med-
ical costs in the Western society. Cartilage defects in the
articular cartilage (AC) of the knee joint (KJ) leads to
localized osteoarthritis and degeneration of the interver-
tebral disc (IVD) [1,2] and are difficult to treat clinically
[3-6]. Cartilage in general is considered to lack or to
have poor repair capacity because of the avascular tissue
structure and poor nutrition of cartilaginous cells pro-
vided by diffusion mechanisms [7-9]. Furthermore, the
chondrocytes or chondrocyte-like cells are entrapped in
the extracellular matrix and have a slow cellular turn-
over, which contributes to less repopulation of the defect
and subsequent regeneration and repair of an injury. In
general, articular cartilage has been considered to be a
tissue containing one cell type, terminally differentiated
chondrocytes. The center part, nucleus pulposus (NP)
of a human adult intervertebral disc, contains mainly
chondrocyte-like cells surrounded by extracellular
matrix, where the most common collagen type is colla-
gen type II and minor fractions of collagen types VI
and XI [8,10]. The NP is enclosed by the annulus fi-
brous (AF), which consists of cells, microfibrillae, and
ring-like structures; the lamellae (collagen type I-rich
fibers) [11,12]. In addition, previous studies detected the
presence of cells expressing progenitor/stem cell markers
in adult cartilage [13-16], and cells isolated from articular
cartilage of KJs have been demonstrated to possess clone-
formation capacity in vitro [17,18].
Limited knowledge exists about the normal regeneration
processes in cartilaginous tissues, and increased know-
ledge in this area is of great importance from clinical and
tissue-engineering perspectives. The homeostasis of many
tissues is regulated by a balance of proliferation and differ-
entiation of adult stem cells [19-21]. In different tissues,
stem cells are located in special anatomic structured mi-
croenvironments termed niches. The location and nature
of these stem cell niches (SNs) can vary, depending on the
tissue type [20,22]. SNs have been identified in, for ex-
ample, skin, bone, intestine, and brain (hippocampus)
[23-26]. In the niche, stem cells undergo mitosis in a
hypothetical asymmetric cell-division pattern, in which
one daughter cell gives rise to a more-differentiated pro-
geny, whereas the other cell maintains the original stem
cell stage [19,27,28].
SNs have been proposed to exist in the intervertebral
disc region, located adjacent to the epiphyseal plate (EP)
and in the outer zone of the AF [29]. In the knee joint,
progenitor cells have been detected in the superficial zone
of articular cartilage [18], and potential stem cell niches
(SNs) have been demonstrated in the synovial membrane
[30,31] and in the zone of the Ranvier groove, (adjacent to
the EP of the knee joint), which anatomically corresponds
to the identified area in the IVD [14,32,33].Currently, limited knowledge exists about the in vivo
potential cellular activities, chemoattractants for stem
cell recruitment, and migration patterns of progenitor
cells originating from these niches (SNs). However,
recently in a lapine model, cells that expressed the
prechondrocytic markers growth- and differentiation factor-
5; GDF5 (GDF5 also termed cartilage-derived morphogenic
protein-1); CDMP1 and bone-morphogenic-protein-14;
BMP14), SOX9 (sex-determining region Y-box) and, for
example, Snail homolog 1, a cytosol protein that is in-
volved in cellular migration, were reported around
these niches (SNs) in the IVD region [29]. The
chondrogenic lineage marker GDF5 was chosen for the
explant studies in the present study because of its role
in joint-development and cartilage-regeneration mecha-
nisms [34-36]. In previous studies, it was demonstrated
that injection of GDF5 into injured/degenerated IVDs
resulted in some positive effects on disc height, im-
provement in magnetic resonance imaging scores [37]
(bovine and lapine models), and extracellular matrix ac-
cumulation [38] (in vitro study, human cells), as well as
in in vivo studies (murine model) [39].
Detection of cell-proliferation rates as well as slow-
cycling cells (for example, stem cells) within different
tissues can be performed with a commonly used in vivo
labeling technique by using 5-bromo-2-deoxyuridine
(BrdU) [22,40]. BrdU is a thymidine analogue, incorpo-
rated into proliferating cells during mitosis [22,27,40,41]
when administered, and can thereafter be detected by
using antibodies directed toward the BrdU molecule.
Cells that do not undergo mitosis during the BrdU ex-
posure period incorporate no BrdU into their DNA.
Hence, after the exposure period, the amount of DNA-
incorporated BrdU decreases in the labeled cells with
each mitotic event, until it decreases below detection
level. Thus, in tissues that have rapid cell turnover, BrdU
will be detected solely at early time points after labeling.
Label-retaining (slow-cycling) cells retain BrdU for a
longer period in, for example, the stem cell niches
[14,22,42], as well as during migration from these niches.
These cells can be traced with BrdU-labeling methods
[26,29,43]. Previously, such migration was reported
(lapine model) in the IVD region by using BrdU method,
in which a shift of the BrdU+ labeled fraction of cells
was observed in different locations, indicating a gradual
cellular migration toward the IVD. Sparse BrdU was ob-
served within the AF and NP [29,42].
Epithelial-mesenchymal transition (EMT) is an evolu-
tionarily well-conserved process, present in many types
of organisms, and means that cells dissolve from a cer-
tain tissue region and migrate to different locations
[44,45]. EMT is common in many processes, such as ac-
tivation of immunoreactive cells (for example, in macro-
phages and in tumor cells that are migrating and
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process, the cytoskeleton of the cells is rearranged to a
adapt a more flattened migratory phenotype [48,49], and
Snail homolog 1, a member of the Snail superfamily pro-
teins [50,51], is one of the key intermediators involved in
rearranging events in the cytoskeleton. Different types of
fluorochrome compounds can further be used as cell
tracers in studies of cellular migration (for example,
carboxyfluorescein diacetate or succinimidyl ester (CDFA-
SE)). CDFA-SE passively diffuses over the cell membrane
and is nonfluorescent until acetate groups of CDFA-SE
are cleaved by intracellular esterases to form fluorescent,
amine-reactive carboxyfluorescein succinimidyl esters.
The succinimidyl ester group reacts with intracellular
amines, and fluorescent conjugates are created and well
retained within the cytosol.
For tracing of migrating cells, nontoxic iron particles (for
example, super-paramagnetic nanoparticles (SPIOs, Endorem
(Guerbet, Villepinte, France))) can be used for the detection
of tumor metastases in the lymphatic system and for
labeling of cells in in vitro and in vivo experiments [52-54].
The aim of the present study was to address the hy-
pothesis of possible cellular migration and migration di-
rections of cells originating from niches potentially
involved in tissue maintenance and regeneration of car-
tilaginous tissues in the intervertebral disc and in the
knee-joint regions in adult mammals.
Materials and methods
Animals
In total, 33 female New Zealand white rabbits were used
in the study. For in situ labeling with cell tracers (n = 12)
and in vivo BrdU labeling (n = 11), the animals were 3
months old, and for the IVD explant study (n = 10), the
animals were 11 months old. The animals demonstrated
good health status and weight gain during the entire ex-
periment time. All animal experiments were approved by
the regional animal ethics committee, Vastra Gotaland re-
gion, Sweden (ethical permissions numbers 262–2010 and
338–2007).
Experimental design
Three main experiments, A through C (Figure 1) were
performed to investigate cellular migration in niche areas
(SNs) of the IVD and KJ (the zone of Ranvier groove).
Preparation of tissues for histology analyses
The tissues were placed in 4% formaldehyde (Histofix,
Gothenburg, Sweden), decalcified by using a 12.5%
EDTA solution, and imbedded in paraffin for sectioning
for microscopy analyses. Paraffin sections (5 to 7 μm)
were deparaffinized with xylene, 2 × 10 minutes, and
rehydrated in 99%, 95%, and 70% ethanol for 5 minutes
in each solution before IHC analyses.Experiment A
IVD explant cultures and isolation of cells from IVDs
for explant assays with flow cytometry A new in vitro
system was designed for the study of the migration
capability of cells in fibrocartilage and IVD explants.
IVD explants were collected from adult rabbits (age 11
to 13 months). A circular mechanical saw was used for
collecting the IVDs from the dead animals. At one side
of the IVD, the bone was kept intact for stability reasons,
and, on the other side, the outer layers of the IVD tissue
were exposed and cultured as explants in cell-culture
inserts (Becton Dickinson, Franklin Lakes, NY, USA) in
six-well plates (Becton Dickinson) (Figure 2A, B).
Two sets of explant studies were performed on IVDs
dissected from rabbits (n = 10). In the first one, the mi-
gration capability of small (<10-μm cell diameter) versus
large cells (>10-μm cell diameter) was studied, and in
the second series, the migration capability of GDF5-
positive cells was examined.
The cells were sorted from the total cell population into
two cell populations by size by using the forward-scatter
function (FSC) or by an antibody directed toward GDF5
of the IVD tissue by using a FACSAria flow cytometer.
After cell sorting, labeling with GDF5 antibody, the cells
were thereafter labeled with two different cell tracer dyes
before application onto the IVD explants.
Explant assay, small versus large cells (series 1) Five
rabbit IVDs collected from four animals (13 months of
age) were minced, pooled, and placed in collagenase type
II (Worthington Biochemicals, Lakewood, NJ, USA) for
24 hours in an incubator (37°C, 7% CO2, 93% air). The
obtained single cells were pooled and washed with
phosphate-buffered saline (PBS) before flow-cytometry
analysis. The small (<10 μm cell diameter) and large
(>10 μm cell diameter) cell populations were sorted
from the total cell population with flow cytometry (see
earlier). The small cells were thereafter labeled with
carboxyfluorescein-diacetate-succinimidyl ester (CFDA-
SE) cell-tracer kit (Invitrogen, Carlsbad, CA, USA), and
the large cells were labeled with Cell tracker Orange
CMRA (Invitrogen), according to the manufacturer’s
instructions.
Eight IVDs were placed in cell-culture inserts in a six-
well plate and cultivated in DMEM/F12 (Gibco, Grand
Island, NY, USA) supplemented with 10% rabbit serum
(collected and pooled from the same animals). A mix of
fluorescence-labeled small (<10-μm cell diameter) and
large cells (>10-μm cell diameter) was carefully pipetted
on top of eight disc explants and allowed to adhere for 2
hours before the rest of the media was added. In
addition, four IVD explants with large cells only and
three IVD explants with small cells only were cultivated
simultaneously.
Figure 1 A schematic overview of the experimental design. (A) A novel experimental assay with fluorochrome-labeled cells to study cellular
migration through IVD explants in vitro was developed. (B) A study with in vivo labeling of DNA with BrdU to examine cell tracing and cell
proliferation in different regions of KJs. In addition, immunostaining for SNAI1 was performed. (C) In situ labeling of cells with fluorochrome and
iron nanoparticles for tracing of migrating cells from niches in the IVD and KJ regions.
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surface of each IVD explant. The cultured explants were
harvested at days 2, 7, 12, and 16, and placed in 4% for-
maldehyde (Histolab, Sweden), and paraffin sections were
prepared. The cultured explants were cut in a sagittal
direction, and the depth of the deepest migrating cells was
measured from the exposed IVD surface. A naive IVD
served as negative control.
Explant assay- GDF5+ cells (series 2) Five IVDs from
four animals (11 months of age) were minced, pooled, and
placed in collagenase type II (Worthington Biochemicals)Figure 2 Cell cultures and morphology of IVD explants. (A) Image of l
inserts in six-well plates. (B) Histology image of a lapine IVD explant. Staininfor 24 hours in an incubator (37°C, 7% CO2, 93% air). The
obtained single cells were pooled and washed with PBS
before flow-cytometry analysis. The GDF5-positive cells
were sorted out from the total cell population by using a
goat anti-GDF5 antibody (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA). The GDF5+ cells were thereafter
labeled with CFDA-SE Vybrandt cell tracer kit (Invitrogen)
according to the manufacturer’s instructions.
Seven intact IVDs were placed in cell-culture inserts
in a six-well plate and cultivated in DMEM/F12 (Gibco)
supplemented with 10% rabbit serum. The GDF5+ cells
were carefully pipetted on top of the IVD explants andapine IVD explants; whole IVDs were used and cultured in cell-culture
g: Alcian Blue Van Gieson (proteoglycans, blue;collagens, red).
Figure 3 Injectionsof cell tracer in IVDs andKJs intoniche regions. X-ray images showing injections of cell tracers (iron nanoparticles or CDFA-SE) in (A) the
IVD niche region and (B) the niche region of KJs located adjacent to the epiphyseal plates (EPs). A 20-gauge needle was used for the injections of cell tracers.
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media was added. The 10,000 labeled cells were pipetted
onto the surface of each IVD explant.Detection of fluorochrome-labeled cells in series 1
and 2 In series 1, results were visualized by using a fluor-
escence microscope Nikon Equilopse80i (Nikon, Tokyo,
Japan), and in series 2, confocal photos with Zeiss LSM
510 confocal microscope were collected of IVDs at 2, 5, 7,
12, and 16 days after initiation of cultures. The cultured
explants were harvested, sectioned sagitally, cell nucleiFigure 4 Viability tests. Upper row: 64.4% small cells (cell diameter <10 μ
(AF and NP) cell population were sorted by size by using the forward-scatt
Outcome of the test of viability was 96.5% viable and 3.5% nonviable cells.
population by using an antibody directed toward GDF5.stained with DAPI, and thereafter, and sections were
covered with Prolong gold mounting media (Invitrogen).Experiment B
Cellular migration studies, in vivo labeling with
BrdU, tibia Eleven rabbits, 3 months of age, were used
in the experiments. Nine rabbits were exposed to BrdU
(20 mg/kg body weight) diluted in the drinking water for
12 days. To monitor drinking rate per day, an exact dose of
water was given to the animals every day. The rabbits were
kept in separate cages during the BrdU administration andm) and 23.7% large cells (cell diameter >10 μm) of the total IVD
er parameter, and gating parameters are indicated by squares.
Lower row: 3. 8% GDF5+ cells were sorted from the total cell
Figure 6 Selected images of migrating GDF5+ cells (green)
from lapine IVDs (sorted with flow cytometry) placed on top of
lapine IVD explants and monitored after 2 and 12 days. Nuclei
stained with DAPI (blue).
Figure 5 Selected images of migrating fluorescence-labeled small (diameter <10 μm) and large (diameter >10 μm) rabbit IVD cells
isolated with flow cytometry (AF and NP) placed on top of lapine IVD explants. The two left images show migrating small cells (green) in
explants at days 2 and 12, and the two right images show migrating large cells (orange) in explants at days 2 and 12 (white arrows).
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BrdU administration) with an overdose of methylpheno-
barbital (Apoteket AB, Sweden). Tibias were collected from
each animal. Three control animals not exposed to BrdU
served as negative controls. Control tissues from small
intestines were used as positive controls for BrdU staining
and for comparison with known stem cell niches for BrdU
expression.
Immunohistochemistry detection of BrdU+ cells
Detection of BrdU-positive cells was performed by using
an antigen-retrieval step with 10 mM citrate buffer, pH
6.0. Sections were incubated in 2 M HCl (Merck, Darm-
stadt, Germany) for 1 hour at 37°C, blocked with 2% bo-
vine serum albumin (BSA; Sigma, St. Louis, MO, USA)
and 0.3% Triton–X100 (Sigma Aldrich) diluted in phos-
phate–buffered saline (PBS), for 30 minutes at room
temperature (RT). Mouse anti-BrdU antibody (DAKO,
Glostrup, Denmark), dilution 1:250, was added, and sec-
tions were incubated for 12 hours at 4°C. Development
was performed with secondary antibody goat anti-mouse,
Alexa Fluor 546 (Invitrogen). 3 hours at RT. Nuclear
staining was performed by using DAPI 0.05 μg/ml solu-
tion (4.6 diamino-2-phenylindole; Sigma) on all sections
for 3 minutes, and samples were covered by using Pro-
long Gold antifade mounting media (Invitrogen). Results
were visualized with a Nikon fluorescence microscope
Eclipse 600 by using NIS-element software. Sections
from tibia collected from non-BrdU-exposed animals
served as negative controls and were analyzed by using
the same protocol as described earlier.
Positive controls were sections from rabbit intestine
collected from the BrdU-exposed rabbits. BrdU cells
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age, potential migration route (PMR), and potential
niche region. The regions were chosen based on previ-
ous studies concerning the presence of stem cell niches
(SNs) located in the zone of Ranvier groove in the KJ re-
gion adjacent to the epiphyseal plate [14,55] and previ-
ously described niche regions in the IVD area [29,42].
Immunohistochemistry: detection of SNAI1+ cells
Sections (KJs) from five animals were prepared for IHC,
as described earlier, and investigated for SNAI1+ (cellular
migration marker) cells. An antigen-retrieval step with
0.1 mM citrate buffer, pH 6.0, was performed, followed
by blocking with 2% BSA. Goat anti-SNAI1 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), dilution 1:100,
was added to the sections, and the sections were incu-
bated for 12 hours at 4°C. Secondary antibody; donkeyFigure 7 Tissue-depth levels and distribution of migrating cells in rab
where different cell types were found after migration within lapine IVD exp
the IVD (AF). Small cells are displayed as dark-blue bars, GDF5+ cells as grey
illustrating the GDF5cell distribution visible as light-green dots in a lapine Ianti-goat, dilution 1:250 Alexa Fluor 546 (Invitrogen)
was added, and sections were incubated for 3 hours at
RT in nuclei staining and mounting media, as described
earlier. Isotype controls and/or sections with primary
antibody omitted were used as negative controls.
Experiment C
In situ labeling with Fe nanoparticle cell tracer The
animals were anesthetized before surgery with intramuscu-
lar injections of fentanyl/fluanisone (HypnormVR; Janssen,
Buckinghamshire, United Kingdom); 0.7 mg/kg body
weight, and an intraperitoneal injection of diazepam
(StesolidVR; Actavis AB, Sweden), 1.5 mg/kg body weight).
Tibias Injections of 10 μl of 1 mg/ml cell tracer (Endorem;
Braun Medical, Melsungen, Germany) (Fe nanoparticles)
were given into the lateral region of the tibias adjacent tobit IVD explants. (A) Bar graphs displaying the deepest tissue level
lants. Mean values of four observations/IVDs seen at different parts of
bars, and large cells as light-blue bars. (B) A 3D confocal image
VD explant at day 12. Magnification: ×200.
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visual control by using a 20-gauge needle (Figure 3). The
right tibia was thereafter imbedded in paraffin, and sec-
tions (5 to 7 μm) were prepared. In each animal, the naïve
tibia from the left leg served as control tissue.
IVDs The animals were anesthetized before surgery, as
described. The cell-tracer compound (Fe nanoparticles)
was injected into niche regions (SNs) of IVDs with a 20-
gauge needle under full visual control. Injections of 10
μl 1 mg/ml Fe nanoparticles into the L2 to L3 level was
performed under full visual control. Naive undisturbed
IVDs served as negative controls (Figure 3).
The animals were sacrificed at 2 to 3 weeks (group 1)
and after 5 to 6 weeks (group 2) with an overdose of
methylphenobarbital (APL), and the lumbar IVDs (LI to
LV) and KJs were collected.Figure 8 Selected images of BrdU+ cells (yellow) in investigated KJ re
predominantly just outside niche region (SN) at day 28. (C) SNAI1+ cells (ye
(note the larger fraction of SNAI1+ cells compared with the BrdU-labeled fr
Articular cartilage (AC) at day 56. (F) SNAI1+ cells in AC. (G) Negative contr
cells (yellow) in PMR. (J) BrdU+ cells in niche (SN) and PMR and BrdU+ cells
Nuclei stained with DAPI (blue).Histology of explants The tibia and IVDs were con-
secutively sectioned (5- to 7-μm sections), serially num-
bered, and every tenth to eleventh section was stained
for orientation with hematoxylin and for Fe-labeled cells
by using standard protocols [56,57].
Tracing of migrating Fe-labeled cells Detection of Fe-
labeled cells was performed in the sections by using
standard Fe-staining protocols with the Prussian blue
reaction (Mallory method) [57]. More than two observa-
tions of Fe-labeled cells per organ was considered a posi-
tive result for each animal.
Results
Three main experiments were performed to investi-
gate cellular migration in cartilaginous tissues of the
IVDs and KJs: (a) an in vitro explants study (IVDs),gions. (A) BrdU+ cell in niche region (SN) at day 14. (B) BrdU+ cells
llow) just outside niche region and in potential migration route (PMR)
action of cells in Figure 6B). (D) Articular cartilage (AC) at day 14. (E)
ol, BrdU; niche region (SN). (H) Negative control, BrdU. AC. (I) SNAI1+
in PMR. (Images J and K are merged from three separate photos).
Figure 10 Bars in figures represent the percentage of BrdU+
cells in AC (grey), the PMR regions (light grey) that originate
from the niche (SN) (black). The mean number of cells for each
localization and time point was used in the calculations. Note the
more-pronounced shift of BrdU+ cells detected in the PMR (potential
migration route) over time, which indicate migration of BrdU+ cells
originating from the niche (SN) into this area.
Figure 9 Images (each image merged from three separate photos) of BrdU+ cells (yellow) in niche region (SN; square) and potential
migration route (PMR) at the time points. (A) 14 days and (B) 56 days in lapine tibia. Nuclei stained with DAPI (blue). Note the decrease in
number of BrdU+ cells in SN and the more abundant BrdU+ cells in PMR at day 56 compared with day 14.
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labeling with Fe particles in both IVDs and KJs
(Figures 1, 2, and 3).
The outcome of the investigation of cellular migration
in experiments A through C was as follows.
Experiment A: Ex vivo study of migration in IVD explants
Flow-cytometry results of lapine IVDs were 64.4%
small cells (<10-μm cell diameter), 23.7% large cells
(>10-μm cell diameter), and 3.8% GDF5+ cells. Via-
bility staining showed 96.5% viable and 3.5% nonviable
cells.
In IVD explants in in vitro cultures, migrating small
cells were labeled with CDFA and large cells (>10 μm),
Orange CMRA labeled, were observed. Small cells
showed a greater capability to migrate through the AF of
the IVD explants compared with large cells. GDF5+ cells
and ≤10-μm cells displayed better migration capability in
IVD explants compared with large cells examined by mi-
gration depth. GDF5+ cells were detected as deep as
1,300 μm (measured from the surface of the explant)
after 16 days (Figures 4, 5, 6, and 7).
Experiment B: cellular-migration studies (in vivo labeling
with BrdU) in KJ (tibia)
BrdU+ cells were observed at early time points (14 days)
in niche regions of KJs, at later time points (28 and 56
days) in a potential migration area (PMR), and inarticular cartilage (AC), indicating a gradual migration
over time of cells from niches toward the AC. Negative
controls showed no staining (Figures 8, 9, and 10).
Detection of SNAI1+ cells in KJ
SNAI1+ cells were detected both along the PMR, just ad-
jacent to the niche border zone, and in the superficial
zone of AC (four of five animals), a few cell layers from
the AC surface. In AC, only a few solitary SNAI1+ cells
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the niche (Figure 8).
Experiment C: In situ Fe- labeling of cells in niches
In vivo, in situ labeling with cell tracer in IVD and KJ
Cells in vivo labeled with the cell tracer (iron
nanoparticles, IVD and KJ) were found in comparable
regions and levels in the animals; located between niches
(SN; lateral to the epiphyseal plate), and the annulus
fibrosus outer region (AFo) and in articular cartilage
(AC) of the KJ, the potential IVD migration-route region
(PMR). Hypothetical potential cellular migration route
(PMR) in IVD and KJ regions and localizations of
detected Fe-labeled + cells are illustrated in Figure 11.
Detection of Fe+ cells in IVDs In the IVD region, Fe+
cells were detected in all animals. In AF, Fe+ cells were
detected 11 of 12 animals; at 2 to 3 weeks (group 1) in
three of three animals, and at 5 to 6 weeks (group 2) in
eight of nine animals as solitary cells. In NP, Fe+ cellsFigure 11 Hypothetical schematic image that displays the investigate
plate), and the annulus fibrosus (AF), AF outer region (AFo), and the poten
In (B) KJ; the niche regions (SN) of (just lateral to the epiphyseal plate) and
(PMR, area between niches (SN) and the AC). Detection of Fe-labeled cellswere found in only two of 12 animals (at 2 to 3 weeks
(group 1) and 5 to 6 weeks (group 2). In the PMR region
of the IVD, Fe+ cells were detected in three of 12
animals; at 2 weeks (group 1), in one of three animals,
and at 5 to 6 weeks (group 2) in two of nine animals.
The Fe+ cells were detected mainly in outer AF lamellae.
In AF, some of the detected cells were located in inter-
spaces between the AF lamellae and aligned in the same
angle as AF in the lamellae; Figures 11 and 12.
Detection of Fe+ cells in KJs In KJ (tibias), Fe+ cells
were detected in 11 of 12 animals in the different inves-
tigated regions: AC, PMR, and niche regions (SNs).
In AC, Fe+ cells were detected six of nine animals; at 2
to 3 weeks (group 1) in two of three animals, and at 5 to 6
weeks (group 2) in four of nine animals as solitary cells,
found at different tissue depths, in different cell-layer
zones; in the superficial and middle zones of AC. Solitary,
Fe+ cells also were found in six of 12 of the animals dis-
tributed in different locations in the PMR region; atd areas. (A) IVD; the niche regions (SNs; just lateral to the epiphyseal
tial migration route (PMR, area between niches (SN) and the IVD).
the articular cartilage (AC) and the potential migration route
in different areas is marked with blue dots.
Figure 12 Images of Fe-labeled cells (blue) in investigated intervertebral disc (IVD) regions. Images from group 1 animals (2 to 3 weeks)
and group 2 animals (5 to 6 weeks) after in situ Fe-labeling of cells in the niche region (SN). (A) Potential migration route (PMR) region. (B) The
annulus fibrosus (AF). (C) Enlarged image of iron-labeled cell in AF indicated by square. (D) The nucleus pulposus (NP). (E) The germinal zone of
the epiphyseal plate (EP). (F) Negative control; AF. Note the elongated migratory phenotype of cells in B and C. Enlarged images of Fe-labeled
cells are enclosed in corners of images. Fe-labeled cells (blue) are indicated by grey arrows. Staining: russian blue reaction (Mallory method).
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weeks (group 2) in five of nine animals (Figures 11
through 13.
No Fe+ cells were detected within the niche regions
(SNs) of IVDs or KJs at any time.
Furthermore, a few observations of solitary Fe+ cells
were also made in adipose, the germinal zone of epi-
physeal plate, cruciate ligaments, and in meniscus tissues
in some of the animals. Negative controls showed no
staining (Figures 11, 12, and 13).
Discussion
The results obtained in this study demonstrate the cap-
ability of cells to migrate through ligaments and fibrous
tissue from niches toward and into cartilaginous tissues.
In this study, we observed cell migration in two different
lapine cartilaginous tissue types: in the intervertebral
disc region (fibrocartilage) and in the knee joint (articu-
lar cartilage/hyaline cartilage). In the IVD region, during
embryogenesis, the notochord is gradually surrounded
and replaced by immigrating mesenchymal cells, which
synthesize the fibrocartilaginous AF and the vertebral
bodies [58,59].
The IVD explant experiments (experiment A) show that
cells are capable of migration within the IVD tissue and
seem to follow the intercellular space direction of the la-
mellae (collagen I-rich fibers) of the AF (Figure 5). The
sorted cell population of the small cells (≤10 μm diameter)displayed a better migration capability compared with lar-
ger cells (>10 μm diameter) and most likely represent a
prechondrocytic cell population that may participate in
normal growth and regeneration of the knee joint and the
IVD. Presumably, small cells are capable of migrating
more efficiently through tissues compared with larger cells
because of the narrow intercellular spaces. Typical stem
cell features are small cellular size and good migration
capability. This is supported by migration to a similar tis-
sue depth by the GDF5+ cells (which are small). Other
bone morphogenic proteins, such as −2, −4, and −7, have
been observed to stimulate chemotactic migration of hu-
man mesenchymal stem cells in vitro (Boyden chamber
model) [60,61]. Stem cell niches have been proposed both
in the intervertebral disc region adjacent to the epiphyseal
plate (EP) and in the outer border of AF [26] and in the
knee joint in the zone of Ranvier groove [14,55].
Cells of different morphology have been observed
within the zone of Ranvier groove, and in the center of
the groove, the cells are more densely packed. This area
of densely packed cells has been demonstrated to harbor
stem cells/progenitor cells [14,29,30,42]. The ring of
LaCroix, a fibrous tissue layer surrounding this groove,
has also been suggested to contain precartilaginous cells;
a niche and serve as a suppliant reservoir of cells for the
germinal zone of the EP by Fenichel et al. [28,33]. The
EP and an intact perichondrial zone are crucial for nor-
mal growth of the long bones [31]. Injuries in childhood,
Figure 13 Images of Fe-labeled cells (blue) in investigated knee-joint (KJ) regions. Images of Fe-labeled cells (blue) from group 1 animals
(2 to 3 weeks) and group 2 animals (5 to 6 weeks) after in situ Fe labeling of cells in the niche region (SN) in investigated knee joint (KJ) regions
(A through D) in articular cartilage (AC). (E) in meniscus (M), (F) in potential migration route (PMR), (G) in cruciate ligament (L), (H) in the PMR
region, and in (I) negative control; AC. Note the elongated migratory phenotype of cells in (G) and (H). Enlarged images of Fe-labeled cells are
enclosed in corners of images. Fe-labeled cells (blue) are indicated by grey arrows. Staining: russian blue reaction (Mallory method).
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ample, Salter-Harris type IV fractures) can result in se-
vere skeletal growth anomalies [32,33].
In experiment B, a shift in number of BrdU+ cells in
different locations with time (in relation to the incorpor-
ation period) indicate migration of slow-cycling cells
(label-retaining cells). The direction of migrating BrdU+
cells was from the niche toward the articular cartilage of
the KJ (present study) and the IVD [29].
Some of the observed cells in experiment C clearly
demonstrated a typical phenotype associated with migra-
tion: elongated cellular shape and cellular protrusions
[48,62]. This was observed both in the IVD region and
in the knee joint (Figures 12 and 13). The expression of
SNAI1, which is involved in the rearrangement of cyto-
skeletal elements during migration, further supports cel-
lular migration in the investigated areas. Furthermore,
the alignment of collagen fibrils has been shown to beimportant for cellular migration (for example, in human
breast carcinoma [63,64]).
The findings in this study are in alignment with a pre-
vious study in osteoarthritic cartilage in the KJ, where
chondroprogenitor cell migrating capacity was demon-
strated in a murine in vitro explant model [65]. Minor
injuries in the articular cartilage of the KJ in young
(skeletally immature) animals have been demonstrated
to heal, whereas larger injuries exhibit a poor or no
self-regeneration capacity [66,67]. Articular cartilage in the
KJ contains populations of progenitor cells [12,15,62].
Further, human articular chondrocytes cultured in vitro
were demonstrated to display phenotypic plasticity with
chondrogenic, adipogenic, and osteogenic potential [14,61].
Similar to the KJ, in an in vitro organ-culture study
(murine epiphyseal fracture model), a cellular migration
pattern was described from the epiphyseal plate into
the IVD, and the migrating cells were classified as
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was not completely described. Additionally, a few obser-
vations have been made of minor regeneration processes
within the IVD, especially in the outer region of the AF
[69-72]. Additionally, the presence of progenitor cells
has been described in the human IVD [73,74], and the
possibility of influencing the proliferation and differenti-
ation of human degenerated IVD cells in vitro was re-
cently reported [16].
Previously, increased cell proliferation and cell migra-
tion in the IVD region [75], in the KJ [76], and in tendon
[77], as an effect of physical exercise (treadmill), was
observed in animal models (murine models), which
indicates that cell proliferation and migration can be
stimulated.Conclusions
The results from this study suggest that the niche re-
gions in KJs and IVD and their cellular activity (for ex-
ample, cellular migration) are important for growth
mechanisms of cartilage, tissue maintenance, and pos-
sibly the regeneration of cartilaginous tissues in adult
mammals. In the IVD and KJ regions, increased know-
ledge about local immature cells and cellular interac-
tions with different biomaterials can be of interest for
tissue engineering and/or potential stimulation of local
progenitor cells in situ when developing biologic treatment
strategies for disc-degeneration disease and osteoarthritis.
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